Data-driven solutions for healthcare's biggest challenge: neurodegenerative disease

Neurological diseases, such as Alzheimer's disease, Parkinson's Disease, and amyotrophic lateral sclerosis (ALS) result in suffering, disability, and death for millions of Americans, and cause more than a trillion dollars in economic damage. There are no effective, disease-modifying treatments for these diseases. In the past, most neuroscientists did not have the tools to disentangle the complex genetics of these diseases. Our platform is specifically designed for neurodegenerative disease, and can analyze thousands of datasets to predict which drugs will work. Verge's genomic network approach offers a breakthrough opportunity to identify drugs that dramatically improve patient outcomes and fundamentally bend the cost curve of pharmaceutical development.

The result: fewer failed drugs, cures for patients within their lifetimes.